OmniAb, Inc. (OABI)

↓ Download CSV

CIK 0001846253 · Nasdaq · Services-Commercial Physical & Biological Research

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, OmniAb, Inc. reported revenue of $18.67M, down 29.3% from the prior year. The company ran a net loss, with a net margin of -347.0%. It held $300.91M in total assets against $33.89M in total liabilities.

Key ratios (FY2025)

-369.5%
Operating margin
-347.0%
Net margin
-24.3%
Return on equity
-29.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202007
Revenue$18.67M$26.39M$34.16M$59.08M$34.75M
Operating Income-$68.97M-$74.50M-$69.42M-$26.65M-$35.61M
Net Income-$64.78M-$62.03M-$50.62M-$22.33M-$27.04M
EPS (Diluted)$-0.57$-0.61$-0.51$-0.26$-0.33
Total Assets$300.91M$325.56M$375.23M$421.21M$304.46M
Total Liabilities$33.89M$37.94M$60.64M$79.84M$70.16M
Shareholders' Equity$267.03M$287.62M$314.58M$341.37M$234.31M$235.54M
Cash & Equivalents$25.52M$27.60M$16.36M$33.39M$0
Operating Cash Flow-$36.45M-$39.66M$2.35M-$3.59M-$5.67M
Capital Expenditures$565.0K$1.88M$1.64M$17.17M$4.07M
Shares Outstanding144.31M121.60M116.86M115.22M0
Dividends Per Share$2.50